Challenges of newborn severe combined immunodeficiency screening among premature infants

Area of Science:

• Immunology
• Neonatal Medicine
• Clinical Diagnostics

Background:

• Newborn screening for severe combined immunodeficiency (SCID) is expanding, necessitating evaluation of its effectiveness and challenges.
• Early diagnosis of SCID is crucial for timely intervention and improved patient outcomes.
• Understanding screening nuances in premature infants is vital as screening programs mature.

Observation:

• A premature infant presented with a strongly positive initial newborn screen for SCID.
• Lymphocyte subset analysis was complicated by a lack of age-matched reference values, prenatal corticosteroid exposure, and potential engraftment issues.
• A repeat newborn screen yielded a normal result, indicating a false positive on the initial screen.

Findings:

• This case underscores the diagnostic complexities of SCID newborn screening in premature neonates.
• Factors such as prematurity, maternal factors, and transfusion history can complicate interpretation of flow cytometry results.
• False positive results in SCID screening can lead to unnecessary parental anxiety and further diagnostic procedures.

Implications:

• There is a need to develop specific reference values and protocols for SCID screening in premature infants.
• Standardizing diagnostic approaches for SCID in this population can improve accuracy and reduce false positives.
• Addressing these challenges is essential for optimizing the benefits of newborn SCID screening programs.